- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04791072
Tele-coaching in Patients With COVID-19
March 9, 2021 updated by: Ilknur Naz, Izmir Katip Celebi University
Effectiveness of Pulmonary Rehabilitation With Tele-coaching in Patients With COVID-19
Respiratory exercise training and aerobic exercise training will be given to patients who have been hospitalized in intensive care due to COVID 19 and underwent IMV, who were hospitalized in the service and underwent NIMV or high-flow oxygen inhalation, and whose respiratory symptoms persist after discharge.
The patients in the study group will be called by phone once a week and a motivating conversation will be made.
No control will be made to the control group.
Before and after the training, 6-minute walking test, MRC dyspnea scale, SGRQ quality of life questionnaire and hospital anxiety depression scale will be applied.
Study Overview
Detailed Description
Some of the patients with COVID 19 pneumonia still have respiratory symptoms despite being treated.
It has been reported that pulmonary rehabilitation programs applied in various models and in a small number to relieve or reduce these symptoms reduce dyspnea, increase exercise capacity and improve quality of life.
There is no study reporting the results of a pulmonary rehabilitation program applied to COVID 19 patients in our country.
The main purpose of this study is to determine the efficacy of pulmonary rehabilitation applied by telecoach to patients with severe COVID 19 pneumonia or persistent respiratory symptoms.
Secondly, it is aimed to present the data of Turkish society to the literature.
In accordance with this purpose investigators planed a randomised control clinical study.
In our study respiratory exercise training and aerobic exercise training will be given to patients who have been hospitalized in intensive care due to COVID 19 and underwent IMV, who were hospitalized in the service and underwent NIMV or high-flow oxygen inhalation, and whose respiratory symptoms persist after discharge.
The patients in the study group will be called by phone once a week and a motivating conversation will be made.
No control will be made to the control group.
Before and after the training, 6-minute walking test, MRC dyspnea scale, SGRQ quality of life questionnaire and hospital anxiety depression scale will be applied.
Study Type
Interventional
Enrollment (Anticipated)
36
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Being treated in intensive care unit due to COVID-19 pneumonia,
- Receiving IMV, NIMV, or high-flow oxygen therapy
- Patients whose respiratory symptoms persist despite discharge
Exclusion Criteria:
- Patients with PCR test +
- Patients without any complaints.
- Patients who are hospitalized and discharged within 10 days
- Patients with orthopedic, neurological, cognitive problems
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Telecoaching group
They will be given breathing exercise training and will be asked to do it every day for 8 weeks.
In addition to breathing exercises, the use of incentive spirometry and aerobic exercise training will be provided.
They will be asked to do breathing exercises, use of incentive spirometry and strengthening exercises for at least 20 minutes every day and 5 times a week.
They will be called by phone once a week and encouraging speeches will be made.
|
Breathing exercise training Use of incentive spirometry Aerobic exercise training Strengthening exercises
|
|
Active Comparator: Control Group
They will be given breathing exercise training and will be asked to do it every day.
In addition to breathing exercises, the use of incentive spirometry and aerobic exercise training will be provided.
They will be asked to do breathing exercises, use of incentive spirometry and strengthening exercises for at least 20 minutes every day and 5 times a week.
There will be no interviews in the control group.
|
Breathing exercise training Use of incentive spirometry Aerobic exercise training Strengthening exercises
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Exercise Capacity
Time Frame: Change from baseline six minute walk distance at 8 week
|
Six Minute- walk test
|
Change from baseline six minute walk distance at 8 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dyspnea Assessment
Time Frame: Change from baseline dyspnea at 8 week
|
Medical Research Council Scale(MRC); the MRC dyspnea scale is a questionnaire that consists of five statements about perceived breathlessness.
(min 1- max 5 point) Higher scores mean a worse outcome.
|
Change from baseline dyspnea at 8 week
|
|
Quality of Life Assessment
Time Frame: Change from baseline quality of life at 8 week
|
St. George Respiratory Questionnaire; Scores range from 0 to 100, with higher scores indicating more limitations.
|
Change from baseline quality of life at 8 week
|
|
Anxiety and Depression
Time Frame: Change from baseline anxiety and depression at 8 week
|
Hospital Anxiety and Depression (HAD); The HADS questionnaire has seven items each for depression and anxiety subscales.
Scoring for each item ranges from zero to three, with three denoting highest anxiety or depression level.
A total subscale score of >8 points out of a possible 21 denotes considerable symptoms of anxiety or depression.
|
Change from baseline anxiety and depression at 8 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
March 1, 2021
Primary Completion (Anticipated)
March 1, 2021
Study Completion (Anticipated)
March 1, 2021
Study Registration Dates
First Submitted
February 27, 2021
First Submitted That Met QC Criteria
March 9, 2021
First Posted (Actual)
March 10, 2021
Study Record Updates
Last Update Posted (Actual)
March 10, 2021
Last Update Submitted That Met QC Criteria
March 9, 2021
Last Verified
March 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IKCSS
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Covid19
-
Anavasi DiagnosticsNot yet recruiting
-
Ain Shams UniversityRecruiting
-
Israel Institute for Biological Research (IIBR)Completed
-
Colgate PalmoliveCompleted
-
Christian von BuchwaldCompleted
-
Luye Pharma Group Ltd.Shandong Boan Biotechnology Co., LtdActive, not recruiting
-
University of ZurichLabor Speiz; Swiss Armed Forces; Universitatsspital ZurichEnrolling by invitation
-
Alexandria UniversityCompleted
Clinical Trials on Exercise
-
National Institute of Neurological Disorders and...TerminatedTraumatic Brain InjuryUnited States
-
University of Texas, El PasoRecruitingKnee Osteoarthritis | Knee Pain Chronic | Central Pain SyndromeUnited States
-
Aksaray University Training and Research HospitalCompletedExercise Training | Lactate Blood Increase | Cognitive Functions | BDNFTurkey (Türkiye)
-
University of Alabama at BirminghamCompletedCystic FibrosisUnited States
-
Toronto Rehabilitation InstituteCompletedAcute Myeloid LeukemiaCanada
-
University of LisbonFundação para a Ciência e a TecnologiaActive, not recruiting
-
University of Missouri-ColumbiaCompleted
-
University of AlcalaCompletedMyofascial Pain | Myofascial Pain Syndrome | Post Needling Soreness | Myofascial Trigger Point PainSpain
-
University College CorkRecruitingDepressive Disorder, MajorIreland
-
Sahmyook UniversityRecruitingChronic Nonspecific Neck PainKorea, Republic of